Every program starts with a secure assessment and a licensed clinician's review. Medication is prescribed only when it is clinically appropriate.
A clinician-led program for adults with obesity, or overweight with a weight-related condition. If appropriate, your clinician may prescribe an FDA-approved weight-management GLP-1 medication such as Wegovy®, Zepbound®, Saxenda® or Foundayo™.
For adults with type 2 diabetes, clinicians may consider FDA-approved GLP-1 medications for blood sugar control, such as Ozempic®, Rybelsus®, Mounjaro®, Trulicity® or Victoza®, prescribed only as part of type 2 diabetes care.
GLP-1 medications are started at a low dose and adjusted over time. Your clinician follows up to review how you feel and decide on each next step.
Practical guidance on eating well with a smaller appetite, staying hydrated, protecting muscle with activity, and building routines that last.
We can help check whether your pharmacy benefit covers a prescribed medication, so you know what your plan reports before it is filled.
Questions about your account, appointments, or next steps? The Coravita Health support team can help by phone or email. Clinical questions go to your clinician.
When your clinician prescribes a medication, it is dispensed by a state-licensed U.S. pharmacy, using FDA-approved, brand-name products. Coravita Health does not dispense medications.
FDA-approved weight-management GLP-1 medications are meant to be used with a reduced-calorie diet and increased physical activity. Our guidance keeps that part simple and realistic, with small changes that fit your kitchen, schedule, and preferences.
Explore Your OptionsYou complete a secure online assessment. A clinician licensed in your state reviews it and may request recent lab results or a video visit before deciding on a plan.
Sometimes. Your clinician may ask for recent labs, such as A1C or kidney function, to make a safe decision. If labs are needed, your clinician will explain what is required.
GLP-1 medications are usually started at a low dose and increased gradually according to the product's labeling. Your clinician decides on each change at follow-up, based on how you're doing.
The most common are nausea, diarrhea, vomiting, constipation, and stomach discomfort, especially when starting or increasing a dose. Your clinician can help you manage them. Please review the Important Safety Information below.
Yes. We can help check whether your pharmacy benefit covers a prescribed medication. Coverage decisions are made by your plan.
Your clinician will explain why and discuss other options, which may include lifestyle-focused care or follow-up with your primary care provider.
This is a summary of important safety information that applies to FDA-approved GLP-1 and GIP/GLP-1 receptor agonist medications. Details vary by product.
In studies in rodents, these medications caused thyroid C-cell tumors. It is not known whether they cause thyroid tumors, including medullary thyroid carcinoma (MTC), in people. Do not use these medications if you or any of your family members have ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician right away if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
Nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, headache, tiredness, and injection-site reactions. These are most common when starting or increasing a dose.
This summary does not include all information about these medications. Please see the full Prescribing Information, including the Boxed Warning, and the Medication Guide for each product, and talk with your clinician or pharmacist. You are encouraged to report negative side effects of prescription drugs to the FDA at fda.gov/medwatch or 1-800-FDA-1088.
A licensed clinician will review your assessment and explain your options, including whether medication is appropriate.